A phase Ia/Ib, dose-escalation/expansion study of the MDM2-p53 antagonist BI 907828 in patients with solid tumors, including advanced/metastatic liposarcoma (LPS) Meeting Abstract
| Authors: | Gounder, M. M.; Yamamoto, N.; Patel, M. R.; Bauer, T. M.; Schöffski, P.; Grempler, R.; Durland-Busbice, S.; Geng, J.; Maerten, A.; LoRusso, P. |
| Abstract Title: | A phase Ia/Ib, dose-escalation/expansion study of the MDM2-p53 antagonist BI 907828 in patients with solid tumors, including advanced/metastatic liposarcoma (LPS) |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680300897 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.3004 |
| Notes: | Meeting Abstract: 3004 -- This meeting was also held virtually -- Source: Wos |
